Le Lézard
Classified in: Health, Business
Subjects: PER, MAT

Goodness Growth Holdings Announces Departure of Chief Operating Officer

MINNEAPOLIS, Dec. 9, 2022 /CNW/ -- Goodness Growth Holdings, Inc. ("Goodness Growth" or the "Company") (CSE: GDNS; OTCQX: GDNSF), a physician-led, science-focused cannabis company and IP developer, today announced the departure of Chief Operating Officer, Christian Gonzalez-Ocasio. The Company intends to engage Mr. Gonzalez as a consultant for an interim period to help ensure a smooth transition with the Company's leadership team.

Chairman and Chief Executive Officer, Kyle Kingsley, MD, commented, "We're very grateful for Christian's many contributions to the Company over the past three years. His leadership was instrumental in our transformation as we expanded manufacturing capabilities and grew our network of dispensaries. We thank Christian for his efforts and wish him well in his future endeavors."

Mr. Gonzalez had been serving as Chief Operating Officer of the Company since November 2020. He previously served as Executive Vice President of Operations, supporting manufacturing and retail initiatives, beginning in October 2019. The Company does not plan to immediately seek a replacement for the Chief Operating Officer position. Responsibilities of the position will be filled by a mix of existing internal resources.

About Goodness Growth Holdings, Inc.

Goodness Growth Holdings, Inc., is a physician-led, science-focused holding company whose mission is to bring the power of plants to the world. The Company's operations consist primarily of its multi-state cannabis company subsidiary, Vireo Health, Inc., and its science and intellectual property developer, Resurgent Biosciences, Inc. The Company manufactures proprietary, branded cannabis products in environmentally friendly facilities and state-of-the-art cultivation sites, and distributes its products through its growing network of Green Goods® and other retail locations and third-party dispensaries. Its team of more than 500 employees are focused on the development of differentiated products, driving scientific innovation of plant-based medicines and developing meaningful intellectual property. Today, the Company is licensed to grow, process, and/or distribute cannabis in five markets and operates 18 dispensaries across the United States. For more information about Goodness Growth Holdings, please visit www.goodnessgrowth.com.

Contact Information

Investor Inquiries:

Media Inquiries:

Sam Gibbons

Amanda Hutcheson

Vice President, Investor Relations

Senior Manager, Communications



(612) 314-8995

 (919) 815-1476


SOURCE Goodness Growth Holdings, Inc.

These press releases may also interest you

at 14:40
The "Global Viral Clearance Market (2022-2027) by Method, Product, Applications, End-user, and Geography, with Competitive Analysis, Impact of COVID-19, and Ansoff Analysis" report has been added to  ResearchAndMarkets.com's offering. The Global...

at 14:30
Today, the Honourable Jean-Yves Duclos, Minister of Health, announced the appointment of the new Chairperson to the Patented Medicine Prices Review Board (PMPRB). Following a merit-based selection process, Thomas J. Digby is appointed for a term of...

at 14:30
Officials from Rendina Healthcare Real Estate ("Rendina") and Baptist Memorial Health Care ("Baptist") assembled earlier this month to celebrate the grand opening of its new Baptist Arlington Emergency Department in Arlington, Tenn. The new...

at 14:26
The National Association for Behavioral Healthcare (NABH) Education and Research Foundation and Manatt have released an issue brief that highlights how telehealth services effectively augment traditional partial hospitalization programs (PHP) and...

at 14:22
Employers' Forum of Indiana recently announced the first major data update to its nationwide hospital price tool, Sage Transparencytm, a free, customizable dashboard that compares metrics of hospital and ASC quality, price, and cost across 4,000...

at 14:20
The "Wound Care Biologics Market Report by Wound Type, by Product, by End User and by Region - Global Forecast to 2029" report has been added to  ResearchAndMarkets.com's offering. The wound care biologics market size is estimated to be USD 1.91...

News published on 9 december 2022 at 16:30 and distributed by: